David Campbell

David Campbell is the founder of Janux Therapeutics, Inc., founded in 2017, where the title held is President, Chief Executive Officer & Director.
Dr. Campbell is also the founder of Thyritope Biosciences, Inc.,Adrenergics, Inc...
Former jobs include President & Chief Executive Officer at Enlibrium, Inc. from 2015 to 2017; Director-Discovery Chemistry at Bayer Corp.; Director-Discovery Chemistry at Affymax Research Institute; Senior Vice President-Drug Discovery & Development at Phenomix Corp.
from 2003 to 2010; Chief Scientific Officer at Afraxis, Inc.; Senior Vice President-Chemical Sciences at ActivX Biosciences, Inc. in 2003; Chief Scientific Officer at Sitari Pharma, Inc. from 2013 to 2019; and Chief Scientific Officer at Iron Horse Therapeutics, Inc. from 2015 to 2019.
Education includes undergraduate studies at Harvey Mudd College and graduate and doctorate degrees from Cornell University.